Revenue: The sum of all revenue fields included for a company's operating activities.
Editas Medicine, Inc. (EDIT) had Revenue of $60.05M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$60.05M |
$-18.87M |
|
-- |
|
$60.05M |
|
$84.01M |
|
$-23.96M |
|
$5.09M |
|
$-18.87M |
|
$-18.87M |
|
$-18.87M |
|
$-18.87M |
|
$-18.87M |
|
$-18.87M |
|
$-23.96M |
|
$-24.60M |
|
75.97M |
|
75.97M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$340.83M |
|
$12.03M |
|
$158.32M |
|
$499.15M |
|
$63.22M |
|
-- |
|
$86.84M |
|
$150.06M |
|
$349.10M |
|
$349.10M |
|
$349.10M |
|
81.77M |
|
| Cash Flow Statement Financials | |
$-132.18M |
|
$-3.73M |
|
$118.04M |
|
$145.40M |
|
$127.53M |
|
$-17.87M |
|
$19.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-39.91% |
|
-39.91% |
|
-- |
|
-31.43% |
|
-31.43% |
|
$-136.90M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
5.89 |
|
15.27 |
|
-5.41% |
|
-5.41% |
|
-3.78% |
|
-5.41% |
|
$4.27 |
|
$-1.80 |
|
$-1.74 |
|